← Back to Tru in the News
PE
Pharmaceutical Executive
July 2026
Operation Trialblazer and Why Clinical Trials are Leaving the US: Q&A with Richard Graham
In a Q&A with Pharmaceutical Executive, Richard Graham discusses Operation Trialblazer. He also addresses why clinical trials are leaving the US.
Read the full article on Pharmaceutical ExecutiveMore from Tru in the News
View allMC
Manufacturing Chemist
ARPA-H SURPASS Programme Targets Phaseless Clinical Trials
October 2026
CTA
Clinical Trials Arena
OCT SoCal 2026: Sound governance and collaboration lead the way as regulation percolates
October 2026
BI
BioProcess International
FDA Rolls Out Expedited Pilot Program to Address Bottlenecks in Clinical Trials
October 2026